Watchlist Price Alert

Armata Pharmaceuticals In... (ARMP)

AMEX: ARMP · Real-Time Price · USD

1.90

0.02 (1.06%)

At close: Jun 25, 2025, 11:30 AM

Armata Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-18.92M	-69.05M	-36.92M	-23.16M	-22.18M	-19.48M	-12.11M	-12.84M	-18.84M
Depreciation & Amortization	1.32M	972K	892K	1.17M	1.11M	1.35M	389K	374K	369K
Stock-Based Compensation	2.89M	938K	3.1M	2.88M	3.48M	4.27M	478K	700K	2M
Other Working Capital	1.66M	-9.69M	-3.23M	-3.41M	-1.42M	-815K	2K	381K	167K
Other Non-Cash Items	-20.75M	29.36M	171K	60K	628K	918K	1.84M	4.33M	5.77M
Deferred Income Tax	n/a	n/a	-171K	-1.31M	-432K	-454K	-328K	-1.3M	-556K
Change in Working Capital	-2.1M	-9.65M	439K	-3.22M	-874K	-2.19M	345K	-457K	670K
Operating Cash Flow	-37.55M	-47.42M	-32.48M	-23.57M	-18.27M	-15.58M	-9.38M	-9.19M	-10.59M
Capital Expenditures	-1.88M	-8.14M	-2.21M	-1.3M	-824K	-131K	-44K	-58K	-279K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	3.01M	65K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	-3.39M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	13.02M	n/a	n/a
Other Investing Acitivies	n/a	10K	n/a	n/a	n/a	3.01M	9.69M	-1.91M	n/a
Investing Cash Flow	-1.88M	-8.13M	-2.21M	-1.3M	-824K	2.88M	-44K	-58K	-279K
Debt Repayment	34.89M	54.03M	n/a	n/a	717K	n/a	n/a	-815K	-100K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-80K
Other Financial Acitivies	-61K	5K	-375K	-801K	-400K	-1M	203K	133K	13K
Financial Cash Flow	34.96M	53.99M	44.02M	25.52M	23.21M	8.97M	12.45M	8.67M	7.21M
Net Cash Flow	-4.47M	-1.57M	9.32M	639K	4.12M	-3.73M	3.02M	-579K	-3.66M
Free Cash Flow	-39.43M	-55.57M	-34.69M	-24.88M	-19.09M	-15.71M	-9.43M	-9.25M	-10.87M